This page lists the SEC filings reported by Puissance Life Science Opportunities Fund VI.
Type | Filed | |
---|---|---|
SC 13D/A | 2023-10-18 | EDGAR |
SC 13D/A | 2023-10-17 | EDGAR |
4 | 2023-10-16 | EDGAR |
SC 13D/A | 2023-06-08 | EDGAR |
144 | 2023-06-07 | EDGAR |
4 | 2023-06-07 | EDGAR |
SC 13D/A | 2023-05-22 | EDGAR |
4 | 2023-05-19 | EDGAR |
144 | 2023-05-18 | EDGAR |
4 | 2021-06-08 | EDGAR |
SC 13D/A | 2021-04-28 | EDGAR |
4 | 2021-04-26 | EDGAR |
SC 13G/A | 2021-02-11 | EDGAR |
4 | 2020-05-22 | EDGAR |
SC 13D | 2020-05-22 | EDGAR |
SC 13G/A | 2020-02-14 | EDGAR |
SC 13G | 2019-03-15 | EDGAR |
4/A | 2018-12-03 | EDGAR |
4 | 2018-12-03 | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.